ClinVar Miner

Submissions for variant NM_025000.4(DCAF17):c.322-14C>T

gnomAD frequency: 0.20151  dbSNP: rs192861143
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital & Research Centre RCV000171450 SCV000221649 likely pathogenic not provided criteria provided, single submitter research
Illumina Laboratory Services, Illumina RCV000341904 SCV000419266 benign Woodhouse-Sakati syndrome 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Mendelics RCV000341904 SCV001136087 benign Woodhouse-Sakati syndrome 2019-05-28 criteria provided, single submitter clinical testing
Invitae RCV000341904 SCV001730002 benign Woodhouse-Sakati syndrome 2024-02-01 criteria provided, single submitter clinical testing
Molecular Genetics, Royal Melbourne Hospital RCV000341904 SCV002503665 benign Woodhouse-Sakati syndrome 2021-10-04 criteria provided, single submitter clinical testing Population allele frequency is 30% (rs192861143, 46,946/157,936 alleles, 5344 homozygotes in gnomAD v2.1). Based on the classification scheme RMH ACMG Guidelines v1.1.1, this variant is classified as Benign. Following criteria met: BA1
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic RCV000341904 SCV002605312 benign Woodhouse-Sakati syndrome criteria provided, single submitter research Mutations in DCAF17 have been associated with a rare syndrome called Woodhouse Sakati Syndrome, which can have diabetes mellitus as one of the presentations.However no sufficient evidence is found to ascertain the role of this particular variant rs192861143, yet.
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000341904 SCV000734158 benign Woodhouse-Sakati syndrome no assertion criteria provided clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001356642 SCV001551866 benign not specified no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV000171450 SCV001808377 likely benign not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000171450 SCV001932888 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV001356642 SCV001974849 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.